James Signorovitch and Susan Ward presented at the 2021 PPMD Duchenne Drug Development Roundtable. James’s presentation is entitled “Considerations for Industry and Regulators” and Susan’s is entitled “Modeling Duchenne: Natural History and Real-World Data”